reversible obstructive airway disease

Acronym

Definition

ROAD

Roadway Express (stock symbol)

ROAD

Reversible Obstructive Airway Disease

ROAD

Retired On Active Duty

ROAD

Radiology, Ophthalmology, Anesthesiology and Dermatology

ROAD

Reorganization Objective Army Divisions

ROAD

Rural Ontario Anarchist Development (Canada)

ROAD

Recherche Opérationnelle et Aide à la Décision (French)

ROAD

Reading Opens All Doors

ROAD

Rebel Outlaw Autoduelists (gaming)

References in periodicals archive	?		Acronyms browser	?		Full browser	?
DAVA's sample request letter, however, promotes the use of VoSpire ER, which it says it's "specially formulated to maintain plasma levels in patients with reversible obstructive airway disease by utilizing a controlled release of albuterol sulfate" and also is "indicated for the relief of bronchospasm in adults and children 6 years of age and older. DAVA Pharmaceuticals, Inc., Fort Lee, NJ, Sept. 21, (DDMAC) by Warning Letter Bulletin XOPENEX(R) brand levalbuterol HCl Inhalation Solution - Marketed through Sepracor's sales force, XOPENEX Inhalation Solution is a short-acting bronchodilator indicated for the treatment or prevention of bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma. SEPRACORE REPORTS NET INCOME OF $11.3 MIL FOR 2ND QTR 2006 by Biotech Financial Reports Food and Drug Administration (FDA) has approved Xopenex[R] brand levalbuterol HCI inhalation solution for the treatment or prevention of bronchospasm in children 6 to 11 years old with reversible obstructive airway disease, such as asthma. Inhalation solution approved for bronchospasm in children. (Product ... by Ear, Nose and Throat Journal	REUG REUGV REUK REUNITE REUP REUR REURIS REURTT REUWS REV REV MED SUISSE ROMANDE REV PROC REV RUL REV-MOP REVA REVAL REVAS REVB REVC REVCOM REVEAL REVEALS REVEI REVEL REVENSA reversible obstructive airway disease REVESCO REVEX REVG REVGEN REVGP REVHS REVI REVIC REVIL REVIS REVIVAL REVL REVM RevMan REVN REVN DT REVO REVP REVPAG REVPAR REVPROC REVR REVRUL REVS REVSOFT	reversible hydrocolloid reversible hydrocolloid reversible i's reversible i's reversible i's reversible i's Reversible Idiopathic Acute Renal Failure Reversible Ileal-Tie in Adult Rabbit Diarrhoea Reversible In-Flight Lock Reversible inhibition of sperm under guidance Reversible Inhibitor of Monoamine Oxidase Type A Reversible Injection Occlusion of Vas Deferens reversible injury reversible ischemic neurologic deficit reversible ischemic neurologic deficit reversible ischemic neurologic deficit reversible ischemic neurologic deficit reversible ischemic neurologic deficit reversible ischemic neurologic disability reversible jacket Reversible Jump Markov Chain Reversible Jump Markov Chain Monte Carlo Reversible lane Reversible lock Reversible lock Reversible markov chain Reversible Markov process Reversible Middle Cerebral Artery Occlusion reversible motor Reversible Motor Pump reversible obstructive airway disease reversible path Reversible Pendulum Reversible photochromism Reversible posterior leukoencephalopathy syndrome Reversible potential Reversible potential difference Reversible potential difference of an electrode reversible process reversible process Reversible processes reversible pulpitis reversible pulpitis Reversible Self-Dual Additive Code Reversible Single Radioactive Immunodiffusion Reversible Spinal Cord Ischemia Model reversible steering gear reversible tramway reversible transducer reversible transit circle Reversible Variable Length Code reversible vascular hyperplasia reversible window reversible-pitch propeller reversibleness reversibleness reversibleness reversibleness

References in periodicals archive

Acronyms browser

Full browser

DAVA's sample request letter, however, promotes the use of VoSpire ER, which it says it's "specially formulated to maintain plasma levels in patients with reversible obstructive airway disease by utilizing a controlled release of albuterol sulfate" and also is "indicated for the relief of bronchospasm in adults and children 6 years of age and older.

DAVA Pharmaceuticals, Inc., Fort Lee, NJ, Sept. 21, (DDMAC) by Warning Letter Bulletin

XOPENEX(R) brand levalbuterol HCl Inhalation Solution - Marketed through Sepracor's sales force, XOPENEX Inhalation Solution is a short-acting bronchodilator indicated for the treatment or prevention of bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma.

SEPRACORE REPORTS NET INCOME OF $11.3 MIL FOR 2ND QTR 2006 by Biotech Financial Reports

Food and Drug Administration (FDA) has approved Xopenex[R] brand levalbuterol HCI inhalation solution for the treatment or prevention of bronchospasm in children 6 to 11 years old with reversible obstructive airway disease, such as asthma.

Inhalation solution approved for bronchospasm in children. (Product ... by Ear, Nose and Throat Journal

REV MED SUISSE ROMANDE